These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 7505257
21. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines. Fenton RG, Turcovski-Corrales SM, Taub DD. J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360 [Abstract] [Full Text] [Related]
22. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen. Diaz LA, Pai R, Endres J, Anthony P, Duzyj C, Bishu S, Morita Y, Fox DA. J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902 [Abstract] [Full Text] [Related]
23. MHC class II molecules regulate growth in human T cells. Nielsen M, Odum N, Bendtzen K, Ryder LP, Jakobsen BK, Svejgaard A. Exp Clin Immunogenet; 1994 Sep; 11(1):23-32. PubMed ID: 7913331 [Abstract] [Full Text] [Related]
24. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro. Cywinski AL, Dunnion DJ, Teobald I, Tucker VC, Browning MJ. Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881 [Abstract] [Full Text] [Related]
25. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins. Yagi J, Uchiyama T, Janeway CA. J Immunol; 1994 Feb 01; 152(3):1154-62. PubMed ID: 7905498 [Abstract] [Full Text] [Related]
26. T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant. Holzer U, Orlikowsky T, Zehrer C, Bethge W, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Immunology; 1997 Jan 01; 90(1):74-80. PubMed ID: 9038715 [Abstract] [Full Text] [Related]
27. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2. Dennig D, Yan Y, Ferguson K, O'Reilly RJ. Cell Immunol; 1996 Aug 01; 171(2):200-10. PubMed ID: 8806788 [Abstract] [Full Text] [Related]
28. Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation. Kraft M, Filsinger S, Krämer KL, Kabelitz D, Hänsch GM, Schoels M. Immunology; 1995 Jul 01; 85(3):461-6. PubMed ID: 7558136 [Abstract] [Full Text] [Related]
29. Induction of hyporesponsiveness in human lymphocytes-T despite their expression of both the co-receptor CD28 and its ligand B7. Friccius H, Siegels-Hübenthal P, Rehbein A, Schlotz E, Pawelec G. Cell Immunol; 1993 Oct 15; 151(2):283-90. PubMed ID: 7691420 [Abstract] [Full Text] [Related]
30. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Brogan PA, Shah V, Klein N, Dillon MJ. Arthritis Rheum; 2004 Feb 15; 50(2):589-97. PubMed ID: 14872503 [Abstract] [Full Text] [Related]
31. Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins. Holliger P, Manzke O, Span M, Hawkins R, Fleischmann B, Qinghua L, Wolf J, Diehl V, Cochet O, Winter G, Bohlen H. Cancer Res; 1999 Jun 15; 59(12):2909-16. PubMed ID: 10383154 [Abstract] [Full Text] [Related]
32. Involvement of CTLA-4 in T-cell anergy induced by staphylococcal enterotoxin A in vitro. Xu GL, Zhu XH, Guo B, Wu YZ. Mol Immunol; 2004 May 15; 41(1):1-8. PubMed ID: 15140570 [Abstract] [Full Text] [Related]
33. Ultraviolet B-exposed major histocompatibility complex class ii positive keratinocytes and antigen-presenting cells demonstrate a differential capacity to activate T cells in the presence of staphylococcal superantigens. Skov L, Baadsgaard O. Br J Dermatol; 1996 May 15; 134(5):824-30. PubMed ID: 8736320 [Abstract] [Full Text] [Related]
34. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7. Damle NK, Klussman K, Leytze G, Ochs HD, Aruffo A, Linsley PS, Ledbetter JA. Cell Immunol; 1993 Apr 15; 148(1):144-56. PubMed ID: 7684325 [Abstract] [Full Text] [Related]
35. Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases. Li ZJ, Omoe K, Shinagawa K, Yagi J, Imanishi K. Microbiol Immunol; 2009 Aug 15; 53(8):451-9. PubMed ID: 19659929 [Abstract] [Full Text] [Related]
36. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma. Newton DW, Dohlsten M, Lando PA, Kalland T, Olsson C, Kotb M. Int J Mol Med; 1998 Jan 15; 1(1):157-62. PubMed ID: 9852214 [Abstract] [Full Text] [Related]
37. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. Vella AT, Mitchell T, Groth B, Linsley PS, Green JM, Thompson CB, Kappler JW, Marrack P. J Immunol; 1997 May 15; 158(10):4714-20. PubMed ID: 9144484 [Abstract] [Full Text] [Related]
38. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. Mawhorter SD, Kazura JW, Boom WH. Immunology; 1994 Apr 15; 81(4):584-91. PubMed ID: 7518797 [Abstract] [Full Text] [Related]
39. Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells. Gidlöf C, Dohlsten M, Kalland T, Tötterman TH. Leukemia; 1995 Sep 15; 9(9):1534-42. PubMed ID: 7544852 [Abstract] [Full Text] [Related]
40. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells. Holzer U, Bethge W, Krull F, Ihle J, Handgretinger R, Reisfeld RA, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Cancer Immunol Immunother; 1995 Aug 15; 41(2):129-36. PubMed ID: 7656271 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]